West Pharma (WST) Misses Q4 EPS by 1c; Issues Light FY15 EPS Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
Tweet
Share
E-mailGet Alerts WST Hot Sheet
Price: $394.03 +0.14%
Revenue Growth %: +2.8%
Financial Fact:
Income before income taxes: 49.3M
Today's EPS Names:
ORPB, PBCO, SICP, More
Revenue Growth %: +2.8%
Financial Fact:
Income before income taxes: 49.3M
Today's EPS Names:
ORPB, PBCO, SICP, More
Join SI Premium – FREE
West Pharma (NYSE: WST) reported Q4 EPS of $0.45, $0.01 worse than the analyst estimate of $0.46. Revenue for the quarter came in at $349.8 million versus the consensus estimate of $348.33 million.
West Pharma sees FY2015 EPS of $1.74-$1.92, versus the consensus of $1.97. West Pharma sees FY2015 revenue of $1.43-1.46 billion, versus the consensus of $1.48 billion.
For earnings history and earnings-related data on West Pharma (WST) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- FVCBankcorp, Inc. (FVCB) Misses Q3 EPS by 2c
- Marten Transport (MRTN) Misses Q3 EPS by 3c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
